Erlotinib 70771-1521-07
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 30, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213065
Need to source Erlotinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erlotinib Hydrochloride | 25 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
70771-1521-07Selected3 BLISTER PACK in 1 CARTON (70771-1521-7) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70771-1521-2)
Other packages for this product(2)
30 TABLET, FILM COATED in 1 BOTTLE (70771-1521-3)
90 TABLET, FILM COATED in 1 BOTTLE (70771-1521-9)